Tag: Talaris
UofL-born cell therapy startup completes $150 million IPO
A University of Louisville startup working to develop a therapy that could improve the lives of kidney transplant recipients and sufferers of severe autoimmune...
UofL-born company secures an additional $115 million to advance cell therapy...
A company born at the University of Louisville has raised an additional $115 million to further develop a therapy that could improve the lives...
UofL-born cell therapy for organ transplants enters Phase 3 trial First...
A cell therapy born at the University of Louisville that could improve the lives of kidney transplant recipients has entered its Phase 3 clinical...
UofL-born company secures $100 million to advance cell therapy
A company born at the University of Louisville has raised $100 million from investors to develop a therapy, based on UofL research, that could...